Compare CZWI & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CZWI | CRBU |
|---|---|---|
| Founded | 1938 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 175.3M | 203.9M |
| IPO Year | N/A | 2021 |
| Metric | CZWI | CRBU |
|---|---|---|
| Price | $18.52 | $1.62 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $8.50 |
| AVG Volume (30 Days) | 46.2K | ★ 1.1M |
| Earning Date | 01-28-2026 | 03-09-2026 |
| Dividend Yield | ★ 1.94% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.29 | N/A |
| Revenue | ★ $58,987,000.00 | $9,295,000.00 |
| Revenue This Year | N/A | $0.22 |
| Revenue Next Year | $11.29 | $4.48 |
| P/E Ratio | $14.44 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.69 | $0.66 |
| 52 Week High | $18.74 | $3.54 |
| Indicator | CZWI | CRBU |
|---|---|---|
| Relative Strength Index (RSI) | 58.76 | 48.31 |
| Support Level | $17.80 | $1.39 |
| Resistance Level | $18.71 | $1.63 |
| Average True Range (ATR) | 0.47 | 0.09 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 70.19 | 56.59 |
Citizens Community Bancorp Inc is a bank holding company that offers traditional community banking services to businesses, Agricultural operators, and consumers, including one-to-four-family residential mortgages. it also offers a variety of loan products including commercial real estate loans, commercial and industrial (C&I) loans, agricultural real estate loans, agricultural operating loans, residential mortgages, home equity lines-of-credit, and consumer loans and offers deposit products through its branches, including demand deposits, various savings and money-market accounts and certificates of deposit. The company's sources of funds are deposits; amortization, prepayments, and maturities of outstanding loans; other short- term investments; and funds provided from operations.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.